Apple will probably release iOS 18.6 in the next few weeks, but it'll likely be focused on squashing bugs and patching security issues.

Lilly is on track to file its oral GLP-1 agonist orforglipron for type 2 diabetes next year after presenting the first phase 3 data with the drug.